Patents by Inventor Michal Schwartz

Michal Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5580555
    Abstract: Administration of tumor necrosis factor to the site of injured central nervous system axons will result in facilitation of the regeneration of axons across the site of the injury. Recombinant human tumor necrosis factor is the preferred substance for such use.
    Type: Grant
    Filed: January 17, 1995
    Date of Patent: December 3, 1996
    Assignee: Yeda Research and Development Co. Ltd.
    Inventor: Michal Schwartz